Pomalidomide-PEG4-acetic acid CAS:2097938-44-6 is a chemical compound that is commonly used in the pharmaceutical industry for the development of new drugs. This compound contains several functional groups, including a PEG (polyethylene glycol) chain and an acetic acid group.
PEG is a widely used polymer that has excellent biocompatibility, solubility, and stability, which makes it an ideal component of drug delivery systems. The acetic acid group, on the other hand, has unique chemical properties that can be used to modify the biological activity of drugs. In the case of Pomalidomide-PEG4-acetic acid, the acetic acid group can be used to modify the activity of Pomalidomide, a drug that is used to treat multiple myeloma and other types of cancer.
By attaching the PEG4-acetic acid group to Pomalidomide, the drug’s pharmacokinetics and pharmacodynamics can be improved, leading to better therapeutic outcomes. Additionally, the PEG4 chain can improve the solubility and stability of the drug, which can enhance its efficacy and reduce potential side effects. The use of Pomalidomide-PEG4-acetic acid represents an important advancement in the field of drug development, and has the potential to significantly improve patient outcomes in the treatment of cancer and other diseases.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
